FDA nod to Exact Sciences’ Cologuard test for colon cancer

August 12, 2014 11:05 AM

18 0

FDA nod to Exact Sciences’ Cologuard test for colon cancer

The Food and Drug Administration (FDA) on Monday gave green signal to Exact Sciences Corp. for a screening test of colon cancer which is first to use DNA sequence of the patients to help detect tumors and unexplained growths that may be potentially fatal.

The Cologuard test from Exact Sciences received FDA nod for spotting irregular mutations in stool samples, which can reveal early signs of colon cancer. The patients who are detected positive for this test further undergo a colonoscopy to confirm the results.

Read more

To category page

Loading...